Prospective Pharmacokinetic and Pharmacogenetic Analysis of Advagraf After Transplantation

Trial Profile

Prospective Pharmacokinetic and Pharmacogenetic Analysis of Advagraf After Transplantation

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jul 2014

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Renal transplant rejection
  • Focus Pharmacogenomic; Pharmacokinetics
  • Acronyms AADAPT
  • Most Recent Events

    • 17 Dec 2012 Planned End Date changed from 1 Jul 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.
    • 01 Oct 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 20 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top